Patients with relapsed or refractory (R/R) multiple myeloma who received a combination of teclistamab, a bispecific ...
Kenorland Minerals Ltd. (TSXV: KLD) (OTCQX: KLDCF) (FSE: 3WQ0) (“Kenorland” or the “Company”) is pleased to provide an update on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback